CONGENITAL VITREOUS ANOMALY

This adverse event was reported 9 times

These drugs are most commonly taken by patients reporting CONGENITAL VITREOUS ANOMALY:

# Drug Count
0 CLOMIPHENE CITRATE 1
1 ESCITALOPRAM 1
2 ESCITALOPRAM OXALATE 1
3 ESCITSLOPRAM 1
4 ETANERCEPT 1
5 FLUOXETINE HYDROCHLORIDE 1
6 INFLIXIMAB 1
7 METHYLPHENIDATE 1
8 METHYLPHENIDATE HYDROCHLORIDE 1
9 OLANZAPINE 1
See all common drugs associated with CONGENITAL VITREOUS ANOMALY

CONGENITAL VITREOUS ANOMALY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CLOMIPHENE CITRATE 1 0.0007
1 OLANZAPINE PAMOATE 1 0.0000
2 PAROXETINE HYDROCHLORIDE 1 0.0000
3 METHYLPHENIDATE HYDROCHLORIDE 1 0.0000
4 OLANZAPINE 1 0.0000
5 SERTRALINE HYDROCHLORIDE 1 0.0000
6 FLUOXETINE HYDROCHLORIDE 1 0.0000
7 ESCITALOPRAM 1 0.0000
8 INFLIXIMAB 1 0.0000
9 ETANERCEPT 1 0.0000
See all drugs enriched for association with CONGENITAL VITREOUS ANOMALY

These drug classes are most commonly taken by patients reporting CONGENITAL VITREOUS ANOMALY:

# Drug class Count
0 Tumor Necrosis Factor Blocker [EPC] 2
1 Atypical Antipsychotic [EPC] 1
2 Central Nervous System Stimulant [EPC] 1
See all common drug classes associated with CONGENITAL VITREOUS ANOMALY

CONGENITAL VITREOUS ANOMALY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Central Nervous System Stimulant [EPC] 1 0.0000
1 Atypical Antipsychotic [EPC] 1 0.0000
2 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
See all drug classes enriched for association with CONGENITAL VITREOUS ANOMALY